Skip to main content

Market Overview

Moderna Teams Up With Uber On COVID-19 Vaccination: What You Need To Know

Share:
Moderna Teams Up With Uber On COVID-19 Vaccination: What You Need To Know

Uber Inc (NYSE: UBER) and Moderna Inc (NASDAQ: MRNA) said they are collaborating on supporting the uptake of COVID-19 vaccines.

What Happened: The two companies will initially work on providing accessible and “credible information” on vaccine safety through Uber’s in-app messaging, according to a statement released Tuesday.

The duo also plans to work in tandem with public health and other organizations to identify additional opportunities to support the efforts to broaden access to the vaccines.

Options under consideration include incorporating ride scheduling directly into the immunization appointment process, and possible integration of vaccine providers’ systems to text reminders and enable patients to book rides in advance for both first or second immunization appointments. 

Why It Matters: In December, Uber committed to millions of free or discounted rides for furthering access to vaccination, as per the statement.

Uber and rival Lyft Inc (NASDAQ: LYFT) are seeking early COVID-19 shots for their workers and are vying for a role in the vaccine drive from the incoming Biden administration, reported the Wall Street Journal.

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX), along with Moderna, received emergency use authorizations from the United States Food and Drug Administration for their respective vaccines in December.

Price Action: Uber shares closed 7.22% higher at $58.54 on Tuesday and gained 0.17% in the after-hours session. On the same day, Moderna shares closed 6.22% higher at $124.55 and fell 0.6% in the after-hours session.

Related Link: Moderna Has Big Plans For 2021

 

Related Articles (UBER + MRNA)

View Comments and Join the Discussion!

Posted-In: Covid-19 VaccinesBiotech News Events General Best of Benzinga

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com